Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
August 8, 2017
Expands pipeline of medicines for the potential treatment of patients with autoimmune disorders. Malvern, PA, August 8, 2017 – Aclaris Therapeutics, Inc. (“Aclaris”) (NASDAQ: ACRS),